Treatment with systemic psoriasis therapy does not worsen the severity of coronavirus disease 2019 (COVID-19), researchers reported via study findings published in the Journal of the European Academy of Dermatology and Venereology.

The retrospective cohort study used RPDR, a clinical data registry, to identify patients with psoriasis and positive COVID-19 reverse transcription polymerase chain reaction (RT-PCR) from March through May 2020. 

Read the full article at